TGFbeta activates mitogen- and stress-activated protein kinase-1 (MSK1) to attenuate cell death

Lars P van der Heide1, Maarten van Dinther, Aristidis Moustakas

  • 1Department of Molecular Cell Biology, and Centre for Biomedical Genetics, Leiden University Medical Center, Postbus 9600, 2300 RC Leiden, The Netherlands. lars.vdh@LICR.uu.se

Insights

Mitogen- and stress-activated kinase 1 (MSK1) acts as a survival pathway, opposing transforming growth factor-beta (TGFβ)-induced cell death. MSK1 inactivation enhances TGFβ-induced apoptosis, suggesting therapeutic potential in cancer.

Area of Science:

  • Cellular signaling pathways
  • Molecular mechanisms of apoptosis
  • Cancer biology

Background:

  • Transforming growth factor-beta (TGFβ) signaling is crucial for cellular processes, including apoptosis.
  • Smad proteins mediate TGFβ-induced gene transcription.
  • The role of mitogen- and stress-activated kinase 1 (MSK1) in TGFβ signaling and cell death remains incompletely understood.

Purpose of the Study:

  • To investigate the role of MSK1 as a regulator of TGFβ-induced cell death.
  • To elucidate the molecular mechanisms by which MSK1 influences apoptosis.
  • To explore the potential of targeting MSK1 and EGF signaling in cancer therapy.

Main Methods:

  • Investigated MSK1 activity in response to TGFβ stimulation.
  • Utilized knockdown of GADD45 and MSK1 to assess their impact on signaling pathways.
  • Analyzed the phosphorylation status of pro-apoptotic BH3-only BCL2 proteins (Bad, Noxa, Bim).
  • Measured caspase-3 activity to quantify apoptosis.
  • Examined the effects of Epidermal Growth Factor (EGF) on MSK1 knockdown phenotypes.

Main Results:

  • TGFβ induces MSK1 activity, dependent on Smad4 and p38 MAPK.
  • GADD45 knockdown abrogates TGFβ-induced p38 and MSK1 activation.
  • MSK1 knockdown enhances TGFβ-induced apoptosis by reducing Bad phosphorylation and increasing Noxa and Bim expression.
  • MSK1 acts as a pro-survival pathway downstream of p38 MAPK.
  • EGF signaling can reverse the effects of MSK1 knockdown.

Conclusions:

  • MSK1 functions as a pro-survival factor that antagonizes TGFβ-induced apoptosis.
  • The p38 MAPK pathway bifurcates, with MSK1 promoting survival and other effectors driving apoptosis.
  • Targeting MSK1 and EGF signaling may re-sensitize cancer cells to TGFβ-induced death.

Related Concept Videos

MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Amplifying Signals via Enzymatic Cascade01:22

Amplifying Signals via Enzymatic Cascade

When a ligand binds to a cell-surface receptor, the receptor's intracellular domain changes shape, which may either activate its enzyme function or allow its binding to other molecules. The initial signal is amplified by most signal transduction pathways. This means that a single ligand molecule can activate multiple molecules of a downstream target. Proteins that relay a signal are most commonly phosphorylated at one or more sites, activating or inactivating the protein. Kinases catalyze the...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...